Abstract
The efficacy and safety of azithromycin and penicillin V in the treatment of acute streptococcal pharyngitis/tonsillitis in paediatric patients were compared in a double-blind, double-dummy prospective study. A total of 489 children (age range, 2–13 years) were randomized to receive treatment with penicillin V (125–250 mg 4 × daily for 10 days) or azithromycin in an oral suspension (10 or 20 mg/kg 1 × daily for 3 days). Only patients with baseline cultures positive forStreptococcus pyogenes and complete clinical and microbiological assessments at the end of therapy and follow-up one month later were included in the efficacy analysis. A satisfactory clinical response (cure or improvement) was recorded in 99% of the 10 mg/kg azithromycin group, 100% of the 20 mg/kg azithromycin group, and 97% of the penicillin V group at the end of therapy (day 12–14). At the follow-up evaluation (day 28–30), relapse rates in patients cured or improved at the end of therapy were 6%, 5%, and 2%, respectively. Bacteriological eradication rates at the end of therapy were 98% in both azithromycin groups and 92% in patients who received penicillin V (p=0.011); pathogen recurrence was recorded at follow-up in 4% of the 20 mg/kg azithromycin group and in 6% of both the 10 mg/kg azithromycin and penicillin V groups. Treatment-related adverse events, the majority of mild to moderate severity, occurred in 13% of patients in the 20 mg/kg azithromycin group, 9% in the 10 mg/kg azithromycin group, and 5% in the penicillin V group. Azithromycin in a dosage of 10 or 20 mg/kg/day once daily for three days was as safe and effective as penicillin V administered four times daily in the treatment of paediatric patients with acute pharyngitis/tonsillitis.
Similar content being viewed by others
References
Bisno AL:Streptococcus pyogenes. In: Mandell GL, Douglas RG, Bennett JE (ed): Principles and practice of infectious diseases. Churchill Livingstone, New York, 1990, p. 519–1528.
Wannamaker WL, Rammelkamp CH, Denny FW, Brink WR, Houser HB, Hahn HO: Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infection with various amounts of depot penicillin. American Journal of Medicine 1951, 10: 673–679.
Bass JW: Antibiotic management of group A streptococcal pharyngotonsillitis. Paediatric Infectious Disease Journal 1991, 10, Supplement: 10–49.
Pichichero ME: Explanations and therapies for penicillin failure in streptococcal pharyngitis. Clinical Pediatrics 1992, 31: 642–649.
Kim KS, Kaplan EL: Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis. Journal of Pediatrics 1985, 107: 642–649.
Raz R, Hamburger S, Flatau E: Clindamycin in the treatment of an outbreak of streptococcal pharyngitis in a kibbutz due to beta-lactamase producing organisms. Journal of Chemotherapy 1990, 2: 182–184.
Colcher IS, Bass JW: Penicillin treatment of streptococcal pharyngitis. A comparison of schedules and the role of specific counselling. Journal of the American Medical Association 1972, 222: 657–659.
Pilot MA, Qin XY: Macrolides and gastrointestinal motility. Journal of Antimicrobial Chemotherapy 1988, 19: 275–276.
Pechère JC: The use of macrolides in respiratory tract infections. International Journal of Antimicrobial Agents 1993, 3, Supplement: 53–61.
Cockburn J, Gibberd RW, Reid AL, Sanson-Fisher RW: Determinants of non-compliance with short-term antibiotic regimens. British Medical Journal 1987, 295: 814–818.
Bright GM, Nagel AA, Bordner J, Desai KA, Dibrino JN, Nowakowska J, Vincent L, Watrous RM, Sciavolino FC: Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-aza-9a-homoerythromycin A derivatives; a new class of macrolide antibiotics, the azalides. Journal of Antibiotics 1988, 41: 1029–1047.
Retsema J, Girard A, Schelkly W, Manousos M, Anderson M, Bright G, Borovoy R, Brennan L, Mason R: Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. Antimicrobial Agents and Chemotherapy 1987, 31: 1939–1947.
Foulds G, Shepard RM, Johnson RB: The pharmacokinetics of azithromycin in human serum and tissues. Journal of Antimicrobial Chemotherapy 1990, 25, Supplement A: 73–82.
Foulds G, Chan KH, Johnson JT, Shepard RM, Johnson RB: Concentrations of azithromycin in human tonsillar tissue. European Journal of Clinical Microbiology & Infectious Diseases 1991, 10: 853–856.
National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial disk susceptibility tests. Order code M2-A4. NCCLS, Villanova, PA, 1988.
Hamill J: Multicentre evaluation of azithromycin and penicillin V in the treatment of acute streptococcal pharyngitis and tonsillitis in children. Journal of Antimicrobial Chemotherapy 1993, 31, Supplement E: 89–94.
Weippl G: Multicentre comparison of azithromycin versus erythromycin in the treatment of paediatric pharyngitis/tonsillitis caused by group A streptococci. Journal of Antimicrobial Chemotherapy 1993, 31, Supplement E: 95–101.
Bottaro G, Rotolo N, Bonforte S, Bucchieri R, De-Luca R, Ficarra G, Gulino AF, Melillo PA, Nicosia A, Prestifilippo F: Evaluation of the clinical efficacy of azithromycin for acute respiratory infections in children. Clinica Terapeutica 1994, 144: 35–39.
Müller O: Comparison of azithromycin versus clarithromycin in the treatment of patients with upper respiratory tract infection. Journal of Antimicrobial Chemotherapy 1993, 31, Supplement E: 137–146.
Hooton TM: A comparison of azithromycin and penicillin V for the treatment of streptococcal pharyngitis. American Journal of Medicine 1991, 91, Supplement 3A: 23S-26S.
Gatley MS: To be taken as directed. Journal of the Royal College of General Practitioners 1968, 16: 39–44.
Bergman AB, Werner RJ: Failure of children to receive penicillin by mouth. New England Journal of Medicine 1963, 268: 1334–1338.
Greenberg RN: Overview of patient compliance with medication dosing: a literature review. Clinical Therapeutics 1984, 6: 592–599.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
O'Doherty, B., Pilfors, G., Quinn, P.T. et al. Azithromycin versus penicillin V in the treatment of paediatric patients with acute streptococcal pharyngitis/tonsillitis. Eur. J. Clin. Microbiol. Infect. Dis. 15, 718–724 (1996). https://doi.org/10.1007/BF01691958
Issue Date:
DOI: https://doi.org/10.1007/BF01691958